Automation in Cell Therapy Manufacturing

Overview

Integration of physical, fluidic, and digital connectivity between instruments in cell therapy workflows to replace unscalable human-mediated steps, enabling the analytical platforms and manufacturing productivity needed for commercial viability. Current cell therapy manufacturing relies on armies of people to move materials and make connections between instruments — a completely unscalable approach that perpetuates the analytical gaps and process variability preventing the industry from reaching commercial productivity and economic targets. Cellular Origins addresses cell therapy automation through three layers of instrument integration — physical consumable movement, fluidic sterile connections, and digital data linkage — representing the connectivity infrastructure prerequisite to both analytics scale-out and manufacturing process control. (Segment 4 (15:00-20:00))